Growth Metrics

Dna X (SONM) Free Cash Flow (2018 - 2025)

Dna X's Free Cash Flow history spans 8 years, with the latest figure at -$2.0 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$2.0 million for Q4 2025, up 55.63% from a year ago — trailing twelve months through Dec 2025 was -$23.5 million (down 170.41% YoY), and the annual figure for FY2025 was -$23.5 million, down 170.41%.
  • Free Cash Flow for Q4 2025 was -$2.0 million at Dna X, up from -$7.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $820000.0 in Q2 2023 to a low of -$17.6 million in Q4 2021.
  • The 5-year median for Free Cash Flow is -$3.8 million (2023), against an average of -$4.4 million.
  • The sharpest move saw Free Cash Flow skyrocketed 110.86% in 2022, then plummeted 4751.52% in 2025.
  • Year by year, Free Cash Flow stood at -$17.6 million in 2021, then surged by 87.35% to -$2.2 million in 2022, then skyrocketed by 83.69% to -$363000.0 in 2023, then plummeted by 1144.35% to -$4.5 million in 2024, then skyrocketed by 55.63% to -$2.0 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$2.0 million, -$7.0 million, and -$4.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.